INFORMATIONAL PURPOSES ONLY. Not medical, legal, or travel advice. Verify with official sources before acting. See corrections log.
Right to try laws and requirements in Arizona. Citations, verification dates, and source links for every data point.
| Dimension | Value | Citation | Source | Verified | Confidence |
|---|---|---|---|---|---|
| Have Enacted State Right to Try Laws | have state RTT laws | Ariz. Rev. Stat. §§ 36-1311 to 36-1314“A manufacturer of an investigational drug, biological product or device may make available the manufacturer's investigational drug, biological product or device to eligible patients pursuant to this article.” | Link | 2026-10-09 | high |
| Enacted Right to Try Laws Before Federal Law | 2014 | Ariz. Proposition 303 (2014), legislatively referred; codified A.R.S. § 36-1311 et seq.“In Arizona, voters, as expected, supported a "right to try" ballot measure that would allow, but not require, drug makers to provide not-yet-approved drugs to people with terminal illnesses.”Note: Arizona's RTT was Proposition 303 (Patient's Right to Try Act), referred by the Legislature and approved by voters at the November 2014 general election (ASU Morrison Institute 2014 ballot guide also describes Prop 303 as put on the ballot by the Legislature). Stored 2015 is wrong. Enactment was by voter approval, not governor signature; official canvass not loaded. | Link | 2026-10-09 | medium |
| Require Individualized Manufacturer Approval for RTT | require individualized approval | Ariz. Rev. Stat. §§ 36-1331 to 36-1336“"Individualized investigational treatment": (a) Means a drug, biological product or device that is unique to and produced exclusively for use by an individual patient based on the patient's own genetic profile.” | Link | 2026-10-09 | high |
| Provide Manufacturer Liability Protection Under RTT | do not provide liability shield sources differ | Ariz. Rev. Stat. §§ 36-1311 to 36-1314; cf. § 36-1336“a state regulatory board may not revoke, fail to renew or take any other action against a physician's license issued pursuant to title 32, chapter 13 or 17 based solely on a physician's recommendation to an eligible patient”Note: Classic RTT article (36-1311 to 36-1314, read in full) has NO manufacturer liability clause; it only protects physician and health-care-institution licenses and penalizes state officials who block access -> FALSE for the classic RTT, so stored TRUE is not supported by that article. However, the separate individualized-treatment article, A.R.S. 36-1336 (https://www.azleg.gov/ars/36/01336.htm), is a 'no private cause of action' clause: 'This article does not create a private cause of action against a manufacturer of an individualized investigational drug, biological product or device', qualified by good-faith compliance and reasonable care. Marked ambiguous because the value depends on whether the RTT 2.0 article counts; best value for the classic RTT = false. | Link | 2026-10-09 | medium |
| Require Insurer Coverage of Investigational Treatments | do not require coverage | Ariz. Rev. Stat. § 36-1312(C)“This article does not require a health care insurer or any state agency to provide coverage for the cost of any investigational drug, biological product or device. A health care insurer may provide coverage” | Link | 2026-10-09 | high |
View full Arizona profile (all layers) · Report an error on this page